InterMune begins Phase II in CF

ITMN began a U.S. Phase II trial of inhaled Actimmune interferon gamma-1b to treat patients with cystic fibrosis (CF). Actimmune is also in Phase III testing to treat idiopathic pulmonary fibrosis and...